rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-31
|
pubmed:abstractText |
Synovial sarcoma (SS) is a malignant soft tissue sarcoma with a poor prognosis because of late local recurrence and distant metastases. To our knowledge, no studies have minimum follow-up of 10 years that evaluate long-term outcomes for survivors.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1569-8041
|
pubmed:author |
pubmed-author:CserhatiM DMD,
pubmed-author:ExnerU GUG,
pubmed-author:FuchsBB,
pubmed-author:GuillotMM,
pubmed-author:HeftiFF,
pubmed-author:JundtGG,
pubmed-author:KaelinAA,
pubmed-author:KlenkeF MFM,
pubmed-author:KriegA HAH,
pubmed-author:MouhsineEE,
pubmed-author:SiebenrockK AKA,
pubmed-author:SpethB MBM,
pubmed-author:von HochstetterA RAR
|
pubmed:issnType |
Electronic
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
458-67
|
pubmed:meshHeading |
pubmed-meshheading:20716627-Adolescent,
pubmed-meshheading:20716627-Adult,
pubmed-meshheading:20716627-Aged,
pubmed-meshheading:20716627-Aged, 80 and over,
pubmed-meshheading:20716627-Child,
pubmed-meshheading:20716627-Female,
pubmed-meshheading:20716627-Follow-Up Studies,
pubmed-meshheading:20716627-Humans,
pubmed-meshheading:20716627-Male,
pubmed-meshheading:20716627-Middle Aged,
pubmed-meshheading:20716627-Neoplasm Metastasis,
pubmed-meshheading:20716627-Neoplasm Recurrence, Local,
pubmed-meshheading:20716627-Retrospective Studies,
pubmed-meshheading:20716627-Sarcoma, Synovial,
pubmed-meshheading:20716627-Survivors,
pubmed-meshheading:20716627-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors.
|
pubmed:affiliation |
Department of Paediatric Orthopaedics, Children's University Hospital (UKBB) Basel. andreas.krieg@ukbb.ch
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|